SUCCESS RATES OF MODERN
CANCER TREATMENTS
Real-world outcome data for immunotherapy, CAR-T, targeted therapy, and combination regimens across major cancer types.
Understanding Cancer Treatment Success Rates
Success rates in oncology are measured by overall response rate (ORR), complete response (CR), progression-free survival (PFS), and overall survival (OS). Modern treatments have dramatically improved these metrics across many cancer types.
โModern treatments have converted many once-fatal cancers into manageable chronic conditions.โ
CAR-T Therapy Response Rates
Response rates from pivotal clinical trials of approved CAR-T products.
CD19 CAR-T (Blood Cancers)
Immunotherapy Outcomes by Cancer Type
| Cancer Type | Treatment | ORR | 5-Year OS |
|---|---|---|---|
| Advanced melanoma | Nivo + Ipi | 58% | 52% |
| NSCLC (PD-L1 >50%) | Pembrolizumab | 45% | 32% |
| Renal cell carcinoma | Nivo + Ipi | 42% | 43% |
| MSI-H solid tumors | Pembrolizumab | 40% | Data maturing |
| Head and neck SCC | Pembrolizumab + chemo | 36% | 23% |
How Much Has Survival Improved?
- 52%5-year OS in metastatic melanoma (was <10%)
- 97.9%ORR with Carvykti in r/r myeloma
- 38 moMedian OS with osimertinib (EGFR+ NSCLC)
Frequently Asked Questions
About Success Rates
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination โ travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Want to Know Your Treatment Success Probability?
Upload your medical reports for a personalized assessment. Our team analyzes your specific cancer profile against the latest outcome data.
This content is for informational purposes only and does not constitute medical advice. Always consult a qualified oncologist before making treatment decisions.